| Autor: |
Alghamdi NJ; Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine, Louisville, KY, USA., Burns CT; PGXL Technologies, LLC, Louisville, KY, USA., Valdes R Jr; Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine, Louisville, KY, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
Critical reviews in clinical laboratory sciences [Crit Rev Clin Lab Sci] 2022 Dec; Vol. 59 (8), pp. 573-585. Date of Electronic Publication: 2022 Jun 23. |
| DOI: |
10.1080/10408363.2022.2080175 |
| Abstrakt: |
The urocortins are polypeptides belonging to the corticotropin-releasing hormone family, known to modulate stress responses in mammals. Stress, whether induced physically or psychologically, is an underlying cause or consequence of numerous clinical syndromes. Identifying biological markers associated with the homeostatic regulation of stress could provide a clinical laboratory approach for the management of stress-related disorders. The neuropeptide, urocortin 3 (UCN3), and the corticotropin-releasing hormone receptor 2 (CRHR2) constitute a regulatory axis known to mediate stress homeostasis. Dysregulation of this peptide/receptor axis is believed to play a role in several clinical conditions including post-traumatic stress, sleep apnea, cardiovascular disease, and other health problems related to stress. Understanding the physiology and measurement of the UCN3/CRHR2 axis is important for establishing a viable clinical laboratory diagnostic. In this article, we focus on evidence supporting the role of UCN3 and its receptor in stress-related clinical syndromes. We also provide insight into the measurements of UCN3 in blood and urine. These potential biomarkers provide new opportunities for clinical research and applications of laboratory medicine diagnostics in stress management. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
